Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone-Receptor-Positive HER2-Negative Breast CancerClin. Cancer Res 2020 Sep 22;[EPub Ahead of Print], A Prat, YH Tsai, T Pascual, L Paré, B Adamo, M Vidal, F Brasó-Maristany, P Galván, JC Brase, V Rodrik-Outmezguine, SRD Johnston, EM Ciruelos, JS Parker
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.